BiotechTube
Home/Cellectis/Philippe Duchateau, Ph.D.
PD

Philippe Duchateau, Ph.D.

Chief Scientific Officer

Cellectis

Therapeutic Areas

OncologyHematological Malignancies

Cellectis Pipeline

DrugIndicationPhase
lasme-cel (UCART22)Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (r/r B-ALL)Phase 2
UCART20x22B-cell MalignanciesPhase 1/2
UCART123Acute Myeloid Leukemia (AML)Phase 1

Leadership Team at Cellectis

AC
André Choulika, Ph.D.
Chief Executive Officer & Director
SD
Steve Doares, Ph.D.
Senior Vice President, US Manufacturing and Site Head
AK
Adrian Kilcoyne, MD, MPH, MBA
Chief Medical Officer
View full Cellectis profile